As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Synergy Pharmaceuticals Inc (NASDAQ:SGYP), a filing with the SEC revealed that on Wednesday, Chairman Gabriel Cerrone purchased 26,000 shares of SGYP, at a cost of $5.98 each, for a total investment of $155,544. Synergy Pharmaceuticals Inc is trading up about 6.8% on the day Friday.
And also on Wednesday, CEO Constantine Karayannopoulos bought $100,002 worth of Molycorp Inc. (NYSE:MCP), buying 16,667 shares at a cost of $6.00 a piece. Before this latest buy, Karayannopoulos made one other purchase in the past year, buying $100,000 shares for a cost of $10.00 a piece. Molycorp Inc. is trading up about 1.6% on the day Friday. Karayannopoulos was up about 28.0% on the purchase at the high point of today's trading session, with MCP trading as high as $7.68 in trading on Friday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.